|Bid||2.1700 x 36200|
|Ask||2.1800 x 29200|
|Day's range||2.1300 - 2.2400|
|52-week range||2.0000 - 5.4500|
|Beta (5Y monthly)||0.63|
|PE ratio (TTM)||12.36|
|Forward dividend & yield||0.12 (5.23%)|
|1y target est||3.88|
Tennenbaum will also join the executive committee of the company that makes Budweiser, Corona and Stella Artois. Dutra, who was CFO for almost 15 years, will remain with the company during a transition period, the company said.
Brazilian beverages firm Ambev SA expects some of the headwinds that hurt third-quarter results to carry into the fourth-quarter, as recent prices hikes in its home country keep a lid on beer volumes, a company executive said on Friday. The largest brewer in Latin American has played down hopes of boosting its operating profit this year in Brazil, its largest market, where tougher competition and a still sluggish economy put pressure on beer sales. "It takes two to three months for the local market to adjust to price hikes, hence why we still see some headwinds carrying into the fourth-quarter," Chief Financial Officer Fernando Tennenbaum told Reuters in an interview.
AB InBev (BUD) is a favored stock due to strong sales trends, strength in global brands and robust outlook. However, soft earnings trend due to currency headwinds and cost inflation cannot be ignored.
The Zacks Analyst Blog Highlights: GW Pharmaceuticals, Scotts Miracle-Gro, Ambev, International Game Technology and Ubisoft Entertainment
AB InBev (BUD) reports strong organic sales growth and top-line beat in first-quarter 2019 on strong volume growth, global premiumization and ongoing revenue-management initiatives.
Boston Beer's (SAM) first-quarter earnings and sales gain from strong shipment volume and depletions growth. The company perks up shipments and depletions view for 2019.
Coca-Cola's (KO) first-quarter earnings and sales top estimates, benefiting from organic revenue growth across all segments as well as execution of growth strategies.
PepsiCo's (PEP) first-quarter 2019 results gain from strong operating performance at international divisions, and North America snacks and beverage businesses. The company reiterates view for 2019.
PepsiCo (PEP) buys the CytoSport business from Hormel Foods for $465 million. Muscle Milk and Evolve brands are likely to enhance PepsiCo's nutrition portfolio.